MRI对原发性肝癌患者TACE术后肿瘤残余或复发病灶显示效果的评价

摘要/Abstract

摘要： 目的探讨核磁共振成像(MRI)对原发性肝癌(PHC)患者肝动脉化疗栓塞(TACE)术后肿瘤残余或复发病灶显示效果评价的应用价值。方法选取我院在2013年12月至2015年12月期间收治符合纳入标准的PHC患者60例,均应用TACE治疗,术后3个月至6个月,每个月时点均采用电子计算机断层扫描(CT)和MRI进行检查,并应用数字减影血管造影(DSA)作为CT和MRI检测结果的评判标准,对PHC患者TACE后肿瘤残余或复发病灶显示效果进行评价。结果 60例PHC患者中,有73个病灶。我院应用DSA后,显示51个病灶为肿瘤残余或复发;22个病灶无异常情况;而使用CT和MRI,分别显示36个和50个病灶有肿瘤残余或复发。MRI的准确性、敏感度均高于CT(χ²=6.245,P=0.012;χ²=6.468,P=0.011)且判断术后肿瘤包膜病灶能力较高(χ²=13.567,P<0.01)。结论 MRI能够较准确地检测PHC患者TACE后肿瘤残余或复发,更好评价肝脏情况。

关键词: 核磁共振成像, 原发性肝癌, 肝动脉化疗栓塞, 肿瘤复发病灶

杨乃忠, 董从松, 刘洋, 潘文艳, 张志平, 陈洁. MRI对原发性肝癌患者TACE术后肿瘤残余或复发病灶显示效果的评价[J]. 肝脏, 2016, 21(11): 951-953.

参考文献

[1] 王振军,胡鸿涛,黎海亮,等. 肝动脉热灌注化疗栓塞对原发性肝癌碘化油沉积及疗效的影响.郑州大学学报(医学版),2015, 50:718-720.
[2] Cheng AL, Thongprasert S, Lim HY, et al. Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma. Hepatology, 2016, 64: 774-784.
[3] 黄丽娜,倪衡建,姜建威,等. 256层CT全肝灌注成像在原发性肝癌肝动脉化疗栓塞术中的价值.中华肝胆外科杂志,2015,21: 512-516.
[4] Hong J, Wang H, Shen G, et al. Recombinant soluble gp130 protein reduces DEN-induced primary hepatocellular carcinoma in mice. Sci Rep, 2016, 6: 24397.
[5] Johnson SP, Ramasawmy R, Campbell-Washburn AE, et al. Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling. Br J Cancer, 2016, 114: 897-904.
[6] 含笑,吕维富.经肝动脉化疗栓塞联合射频消融治疗原发性肝癌远期疗效的荟萃分析.介入放射学杂志,2013,22: 387-391.
[7] 胡鸿涛,黎海亮,郭晨阳等.经肝动脉化疗栓塞联合射频消融治疗第二肝门区恶性肿瘤的临床疗效观察.中华肝脏病杂志,2016,24: 133-135.
[8] Montalbano M, Curcurù G, Shirafkan A, et al.Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion. PLoS One, 2016, 11: e0153613.
[9] Takeda A, Sanuki N, Tsurugai Y,et al. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Cancer, 2016, 122: 2041-2049.
[10] 濮珏彪,王学锋,彭奕冰,等. 血清异常凝血酶原检测在原发性肝癌临床诊断中的应用.检验医学,2014, 29: 270-273.
[11] 乔彬彬,虞希祥,王舒婷,等. TACE术中灌注氟尿嘧啶、奥沙利铂及吡柔比星治疗原发性肝癌的临床效果分析.介入放射学杂志,2015, 24:349-353.
[12] Wang K, Guo WX, Chen MS, et al.Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis. Medicine (Baltimore), 2016, 95: e3015.
[13] Hyun SH, Eo JS, Lee JW, et al. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study. Eur J Nucl Med Mol Imaging, 2016,March 2 (Published online).
[14] 苏阳春.原发性肝癌MRI检查的应用价值分析.中外医疗,2014: 181-182.
[15] Guo W, He X, Li Z, et al. Combination of Transarterial Chemoembolization (TACE) and Radiofrequency Ablation (RFA) vs. Surgical Resection (SR) on Survival Outcome of Early Hepatocellular Carcinoma: A Meta-Analysis. Hepatogastroenterology, 2015, 62: 710-714.
[16] 李玉柱,张玉敏,寇永妹, 等. MRI、CT联合ELISA法检测血清AFP-L3含量在原发性肝癌诊断中的价值. 现代肿瘤医学, 2015, 23: 501-504.